US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 192 actively recruiting studies with Wisconsin sites out of 192 registered in total. The busiest research areas in Wisconsin are Acute Myeloid Leukemia, Breast Cancer, Heart Failure. Leading sponsors running trials in the state include University of Wisconsin, Madison, National Cancer Institute (NCI), Medical College of Wisconsin. By stage, Wisconsin trials break down as Phase 1 (26), Phase 2 (44), Phase 3 (59), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
192
Recruiting Now
192
← Back to US Map
Top Conditions in Wisconsin
Acute Myeloid Leukemia (4)Breast Cancer (4)Heart Failure (4)Multiple Myeloma (3)Chronic Lymphocytic Leukemia (3)Ovarian Cancer (3)Pancreatic Adenocarcinoma (3)Stage III Pancreatic Cancer AJCC v8 (3)Advanced Solid Tumors (2)Advanced Solid Tumor (2)Non-Small Cell Lung Cancer (NSCLC) (2)Endometrial Cancer (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 192 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 192. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Breast Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT05934487 N/A
Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Condition
Heart Failure NYHA Class II
Enrollment
1,750 pts
Location
United States, Belgium, Ireland
Sponsor
Endotronix, Inc.
View Trial →
NCT06962800 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Primary Membranous Nephropathy
Enrollment
180 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
View Trial →
NCT03808922 Phase 3
Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substu...
Condition
Lower Respiratory Tract Infection
Enrollment
274 pts
Location
United States, Australia, China
Sponsor
Ansun Biopharma, Inc.
View Trial →
NCT01166009 N/A
Recruiting
CIBMTR Research Database
Condition
Autologous Stem Cell Transplantation
Enrollment
99,999,999 pts
Location
United States
Sponsor
Center for International Blood
View Trial →
NCT05580419 N/A
Recruiting
Impact of 4PCP on Practitioner and Patient Outcomes
Condition
Chronic Pain
Enrollment
1,188 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT05099003 Phase 1, Phase 2
Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diag...
Condition
Malignant Glioma
Enrollment
132 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT01574053 N/A
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition
Huntington's Disease
Enrollment
35,000 pts
Location
United States, Argentina, Australia
Sponsor
CHDI Foundation, Inc.
View Trial →
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
View Trial →
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT07086976 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzab...
Condition
Autoimmune Haemolytic Anaemia
Enrollment
90 pts
Location
United States, Argentina, Austria
Sponsor
Sanofi
View Trial →
NCT07388524 Phase 3
Recruiting
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Preven...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
336 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05001880 Phase 2
Recruiting
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Condition
Peritoneal Malignant Mesothelioma
Enrollment
66 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06116682 Phase 2
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Co...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
88 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05653232 N/A
Recruiting
Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-In...
Condition
HCV
Enrollment
120 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT07221149 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Enrollment
690 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
View Trial →
NCT06975657 N/A
Recruiting
Well-being Skills for Reentry
Condition
Formerly Incarcerated Adults
Enrollment
60 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT05059444 N/A
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Condition
Bladder Carcinoma
Enrollment
2,020 pts
Location
United States, France, Germany
Sponsor
Guardant Health, Inc.
View Trial →
NCT05918211 Phase 3
Recruiting
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Condition
Single Ventricle Heart Disease
Enrollment
436 pts
Location
United States, South Korea
Sponsor
Mezzion Pharma Co. Ltd
View Trial →
NCT05567744 N/A
Recruiting
Registry for CADASIL
Condition
Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy
Enrollment
2,500 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06844383 Phase 2
Recruiting
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Canc...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
126 pts
Location
United States
Sponsor
Prostate Cancer Clinical Trial
View Trial →
NCT06366464 Phase 3
Recruiting
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Condition
Prader-Willi Syndrome
Enrollment
134 pts
Location
United States, Australia, Belgium
Sponsor
Harmony Biosciences Management
View Trial →
NCT06091865 Phase 3
Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and Ho...
Condition
Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment
904 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07496567 Phase 2, Phase 3
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-...
Condition
Macular Degeneration
Enrollment
960 pts
Location
United States, Brazil, Colombia
Sponsor
EyeBiotech Ltd.
View Trial →
Page 7 of 8 — 192 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology